200,000+ products from a single source!
sales@angenechem.com
2062-84-2 | 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-
CAS No: 2062-84-2 Catalog No: AG002AL0 MDL No:
Product Description
Catalog Number:
AG002AL0
Chemical Name:
2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl]-1,3-dihydro-
CAS Number:
2062-84-2
Molecular Formula:
C22H24FN3O2
Molecular Weight:
381.4433
IUPAC Name:
3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one
InChI:
InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)
InChI Key:
FEBOTPHFXYHVPL-UHFFFAOYSA-N
SMILES:
Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2
UNII:
97O6X78C53
Properties
Complexity:
556
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
381.185g/mol
Formal Charge:
0
Heavy Atom Count:
28
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
381.451g/mol
Monoisotopic Mass:
381.185g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
52.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.7
Literature
| Title | Journal |
|---|---|
| Why are most phospholipidosis inducers also hERG blockers? | Archives of toxicology 20171201 |
| Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. | Synapse (New York, N.Y.) 20120901 |
| Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature. | Journal of clinical pharmacology 20120701 |
| Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound. | Bioorganic & medicinal chemistry 20110601 |
| Spontaneous coronary artery dissection in a young man - case report. | Journal of cardiothoracic surgery 20110101 |
| Epistemological and ethical assessment of obesity bias in industrialized countries. | Philosophy, ethics, and humanities in medicine : PEHM 20110101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. | Bioorganic & medicinal chemistry 20100715 |
| Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. | European journal of nuclear medicine and molecular imaging 20080401 |
| Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans. | Nuclear medicine and biology 20080401 |
| [Recurrent dysregulation of body temperature during antipsychotic pharmacotherapy]. | Psychiatrische Praxis 20080301 |
| The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). | BMC psychiatry 20080101 |
| Comparative evaluation of hERG potassium channel blockade by antipsychotics. | Methods and findings in experimental and clinical pharmacology 20070901 |
| Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. | ChemMedChem 20070601 |
| Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole. | The international journal of neuropsychopharmacology 20070201 |
| Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020 |
| [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. | No to shinkei = Brain and nerve 20060601 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Synthesis and characterization of selective dopamine D2 receptor antagonists. | Bioorganic & medicinal chemistry 20060201 |
| Benperidol for schizophrenia. | The Cochrane database of systematic reviews 20050418 |
| Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. | Pharmacopsychiatry 20040301 |
| Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol. | Journal of clinical psychopharmacology 20040201 |
| In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030401 |
| Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. | European journal of nuclear medicine and molecular imaging 20030301 |
| Benperidol for schizophrenia. | The Cochrane database of systematic reviews 20020101 |
| Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20011101 |
| Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. | Molecular psychiatry 19980301 |
| [Drug-induced asterixis amplified by relative hypoglycemia]. | Der Nervenarzt 19960401 |
| Patients' refusal of surgery after innovar premedication. | Plastic and reconstructive surgery 19730201 |
| Reduction of the psychotomimetic and circulatory side-effects of ketamine by droperidol. | Anesthesiology 19721101 |
| Acute rigidity with small intravenous dose of Innovar. A case report. | Anesthesia and analgesia 19720101 |
| Effects of Innovar and innovar plus nitrous oxide on muscle tone and 'H' reflex. | Anesthesia and analgesia 19710101 |
| Haloperidol-desipramine interaction in mice, rats and man. | Chemico-biological interactions 19700801 |
| Innovar--nitrous oxide--oxygen: a four-year clinical appraisal of neuroleptanalgesia. | Anesthesia and analgesia 19690101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.